The global Smart Insulin Pens Market is experiencing substantial growth, driven by the increasing prevalence of diabetes, ...
Market OverviewThe Global Smart Insulin Pens Market was valued USD 102.86 Million in 2022 and is anticipated to reach a value ...
Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback